AGP Picks
View all

The best science and technology news from Syria

Provided by AGP

Syria Technology Digest
Got News to Share?
Got News to Share? globe Explore more publications!

Syria Technology Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Syria Technology Digest.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on May 18, 2026

Intuitive Machines Announces Two Prime Lunar Reconnaissance Contracts
May. 18, 2026

Intuitive Machines Announces Two Prime Lunar Reconnaissance Contracts

Indeterminate GlobeNewswire
Egnyte Targets Data Fragmentation with Automated Email and Content Governance
May. 18, 2026

Egnyte Targets Data Fragmentation with Automated Email and Content Governance

Indeterminate GlobeNewswire
IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing
May. 18, 2026

IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing

Indeterminate GlobeNewswire
Degen Coin Announces Launch of Community-Driven Brand Identity Inspired by Crypto Degen Culture
May. 18, 2026

Degen Coin Announces Launch of Community-Driven Brand Identity Inspired by Crypto Degen Culture

Indeterminate GlobeNewswire
Cullinan Therapeutics to Present Initial Clinical Data for CLN-978 in Treatment-Refractory Rheumatoid Arthritis and Systemic Lupus Erythematosus at EULAR 2026 Congress
May. 18, 2026

Cullinan Therapeutics to Present Initial Clinical Data for CLN-978 in Treatment-Refractory Rheumatoid Arthritis and Systemic Lupus Erythematosus at EULAR 2026 Congress

Indeterminate GlobeNewswire
Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing
May. 18, 2026

Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing

Indeterminate GlobeNewswire
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May. 18, 2026

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May. 18, 2026

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Berto Acquisition Corp. II Announces Closing of Upsized $315,100,000 Initial Public Offering
May. 18, 2026

Berto Acquisition Corp. II Announces Closing of Upsized $315,100,000 Initial Public Offering

Indeterminate GlobeNewswire
Inspired Announces CFO Transition
May. 18, 2026

Inspired Announces CFO Transition

Indeterminate GlobeNewswire
Certara to Participate in Upcoming Investor Conferences
May. 18, 2026

Certara to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
May. 18, 2026

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
GSI Technology Awarded Phase I of Smart City Project in Taiwan, Advancing Commercial Deployment of Gemini-II
May. 18, 2026

GSI Technology Awarded Phase I of Smart City Project in Taiwan, Advancing Commercial Deployment of Gemini-II

Indeterminate GlobeNewswire
Mineralys Therapeutics Announces Presentation of New Data from the Phase 3 Launch-HTN Trial of Lorundrostat at the 35th European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)
May. 18, 2026

Mineralys Therapeutics Announces Presentation of New Data from the Phase 3 Launch-HTN Trial of Lorundrostat at the 35th European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)

Indeterminate GlobeNewswire
AvePoint to Participate in Upcoming Investor Conferences 
May. 18, 2026

AvePoint to Participate in Upcoming Investor Conferences 

Indeterminate GlobeNewswire
BGSF, Inc. Participating in the 16th Annual East Coast IDEAS Conference at The Westin New York at Times Square
May. 18, 2026

BGSF, Inc. Participating in the 16th Annual East Coast IDEAS Conference at The Westin New York at Times Square

Indeterminate GlobeNewswire
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May. 18, 2026

C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May. 18, 2026

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Beam Therapeutics Presents Recently Reported Topline Clinical Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the American Thoracic Society (ATS) 2026 International Conference
May. 18, 2026

Beam Therapeutics Presents Recently Reported Topline Clinical Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the American Thoracic Society (ATS) 2026 International Conference

Indeterminate GlobeNewswire
Belite Bio Receives Orphan Drug Status for Tinlarebant in Stargardt Disease in Switzerland
May. 18, 2026

Belite Bio Receives Orphan Drug Status for Tinlarebant in Stargardt Disease in Switzerland

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
LinkedIn Facebook

Sign up for:

Syria Technology Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.